These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 922480)

  • 1. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.
    Brownstein MJ; Mroz EA; Tappaz ML; Leeman SE
    Brain Res; 1977 Oct; 135(2):315-23. PubMed ID: 922480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
    Jessell TM; Emson PC; Paxinos G; Cuello AC
    Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of discrete kainic acid-induced lesions of corpus caudatus and globus pallidus on glutamic acid decarboxylase of rat substantia nigra.
    Di Chiara G; Morelli M; Porceddu ML; Mulas M; Del Fiacco M
    Brain Res; 1980 May; 189(1):193-208. PubMed ID: 7363085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for descending pallido-nigral GABA-containing neurons.
    McGeer PL; Fibiger HC; Maler L; Hattori T; McGeer EG
    Adv Neurol; 1974; 5():153-60. PubMed ID: 4155231
    [No Abstract]   [Full Text] [Related]  

  • 5. Glutamic acid decarboxylase (GAD) activity in the rat substantia nigra after discrete bilateral kainic acid-induced lesions of the caudate-putamen and globus pallidus: correlation with locomotor activity.
    Al-Shabibi UM; Davies JA
    Brain Res; 1981 Jun; 213(2):460-6. PubMed ID: 7248771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons.
    Kincaid AE; Albin RL; Newman SW; Penney JB; Young AB
    Neuroscience; 1992 Dec; 51(3):705-18. PubMed ID: 1488118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical demonstration of differential substance P-, met-enkephalin-, and glutamic-acid-decarboxylase-containing cell body and axon distributions in the corpus striatum of the cat.
    Beckstead RM; Kersey KS
    J Comp Neurol; 1985 Feb; 232(4):481-98. PubMed ID: 2579980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitters contained in the efferents of the striatum.
    Staines WA; Nagy JI; Vincent SR; Fibiger HC
    Brain Res; 1980 Aug; 194(2):391-402. PubMed ID: 6155976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection.
    Nagy JI; Carter DA; Fibiger HC
    Brain Res; 1978 Dec; 158(1):15-29. PubMed ID: 21348349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A striatal source of glutamic acid decarboxylase activity in the substantia nigra.
    Nagy JI; Fibiger HC
    Brain Res; 1980 Apr; 187(1):237-42. PubMed ID: 7357470
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen.
    Lindefors N; Brené S; Persson H
    Brain Res Mol Brain Res; 1990 Apr; 7(3):207-12. PubMed ID: 2159580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered neurotransmitter synthetic enzyme activity in some extrapyramidal nuclei after lesions of the nigro-striatal dopamine projection.
    Nagy JI; Vincent SR; Fibiger HC
    Life Sci; 1978 May; 22(20):1777-82. PubMed ID: 672427
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
    Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
    Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
    Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
    Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence.
    Somers DL; Beckstead RM
    Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions.
    Walaas I; Fonnum F
    Brain Res; 1979 Nov; 177(2):325-36. PubMed ID: 497834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin and distribution of glutamate decarboxylase in substantia nigra of the cat.
    Fonnum F; Grofová I; Rinvik E; Storm-Mathisen J; Walberg F
    Brain Res; 1974 May; 71(1):77-92. PubMed ID: 4821421
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for substance P in the striato-nigral tract.
    Mroz EA; Brownstein MJ; Leeman SE
    Brain Res; 1977 Apr; 125(2):305-11. PubMed ID: 856411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descending substance P-containing pathway: a component of the ansa lenticularis.
    Palkovits M; Mroz EA; Brownstein MJ; Leeman SE
    Brain Res; 1978 Nov; 156(1):124-8. PubMed ID: 308833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.